Næste

Automatisk afspilning

Dr. Ai on Potential With Mogamulizumab in CTCL

3 Visninger • 08/09/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, speaks to the relevance of mogamulizumab (Poteligeo) in treating Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning